Biocon Limited has informed the Exchange regarding a press release dated September 26, 2024, titled "Biocon Limited partners with Tabuk Pharmaceuticals to commercialize its Glucagon-like peptide-1 (GLP -1) products in the Middle East region".
Press Release Sep 26 2024
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from Biocon
- Press Release Sep 25 2024
- Press Release Aug 29 2024
- Press Release Aug 08 2024
- Press Release May 24 2024
- Press Release May 21 2024
Later from Biocon
- Biocon Limited partners with Tabuk Pharmaceuticals to commercialize its Glucagon-like peptide-1 products in the Middle East region
- Biocon Limited Press Release Oct 03 2024
- Press Release Oct 08 2024
- Biocon Biologics Announces Results of Aflibercept Switching Study at American Academy of Ophthalmology Annual Meeting
- Press Release Oct 25 2024
Follow Biocon into a list and get an email when it puts out news.
Follow Biocon